Clinical Studies

FRD™ detects intracervical cancer: On the ectocervix and in the canal

Clinical Studies

Zbigniew Wrobel, doctor, gynecologist-obstetrician, Head of the Gynecology and Obstetrics Clinic Medi-Lab s.c. Wrobel and Associates in Swidnica, Poland

Clinical practice and a number of tests have confirmed the importance of the FRD™ examination as an effective additional diagnostic method for the detection of precancerous cervical lesions and cervical cancer. Its results overlap with other results of research into RSM screening. What’s more, and what is very important – FRD™ has the advantage that it allows the user to determine not only the condition of the ectocervix but also the cervical canal.

Screening for cervical cancer has many challenges; it takes too long, it is not accessible to everyone, it is not accurate enough and there is a lack of specialists. To help these problems, the FRD™ test was developed, which is a quick, easily available, inexpensive and accurate method of detecting precancerous and neoplastic conditions of the cervix . The result in the office after 1.5 minutes.

Published:  08/2020

Share :

Share on facebook
Share on twitter
Share on linkedin
Close Menu

In R&D Pipeline